Charles River Laboratories International Inc

CRL

Company Profile

  • Business description

    Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

  • Contact

    251 Ballardvale Street
    WilmingtonMA01887
    USA

    T: +1 781 222-6000

    E: askcharlesriver@crl.com

    https://www.criver.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2024

    Employees

    21,400

Stocks News & Analysis

stocks

Microsoft earnings: Strength in cloud, guidance mixed

We think investors should be on board when Azure accelerates in the third quarter.
stocks

Chart of the week: Small caps lagging

This week's chart of the week comes from Morningstar's Market Strategist's take on small caps
stocks

An impending merger just raised our fair value for this ASX retail giant

The deal is set to deliver enhanced scale, cost savings and new synergies.  

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,422.1017.40-0.21%
CAC 407,350.3777.99-1.05%
DAX 4019,077.54179.80-0.93%
Dow JONES (US)41,763.46378.08-0.90%
FTSE 1008,110.1049.53-0.61%
HKSE20,317.3363.31-0.31%
NASDAQ18,095.15512.78-2.76%
Nikkei 22539,081.25196.14-0.50%
NZX 50 Index12,580.8058.10-0.46%
S&P 5005,705.45108.22-1.86%
S&P/ASX 2008,160.0020.40-0.25%
SSE Composite Index3,279.8213.590.42%

Market Movers